Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components

References

• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.
   PubMed Web of Science ®Google Scholar
• Prockop DJ, Brenner M, Fibbe WE, Horwitz E, Le Blanc K, Phinney DG, . Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 2010;12:576–8.
   PubMed Web of Science ®Google Scholar
• EMA. The European Agency for the Evaluation of Medicinal Products. Guideline on the Requirements and Controls Applied to Bovine Serum Used in the Production of Immunological Veterinary Medicinal Products. 2002a;EMEA/CVMP/743/00.
   Google Scholar
• EMA. The European Agency for the Evaluation of Medicinal Products. Note for Guidance on the Use of Bovine Serum in the Manufacture of Human Biological Medicinal Products (Draft). 2002b;CPMP/BWP/1793/02.
   Google Scholar
• EMA. The European Agency for the Evaluation of Medicinal Products. Note for Guidance on Minimizing the Risk of Transmitting Animal Spongiform Encephalopathy Agents via Human and Veterinary Medicinal Products. 2003;EMEA/410/01 revision 2.
   Google Scholar
• Ng F, Boucher S, Koh S, Sastry KSR, Chase L, Lakshmipathy U, . PDGF, TGF-b1, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 2008;112:295–307.
   PubMed Web of Science ®Google Scholar
• Mimura S, Kimura N, Hirata M, Tateyama D, Hayashida M, Umezawa A, . Growth factor-defined culture medium for human mesenchymal stem cells. Int J Dev Biol. 2011; 55:181–7.
   PubMed Web of Science ®Google Scholar
• Tyndall A, Walker U, Cope A, Dazzi F, De Bari C, Fibbe W, . Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arth Res Ther. 2007;9:301.
   PubMed Web of Science ®Google Scholar
• Burnouf T, Kuo YP, Huang CT, Tseng YH, Lin CT, Su CY. A virally inactivated platelet-derived growth factor/vascular endothelial growth factor concentrate fractionated from human platelets. Transfusion. 2010;50:1702–11.
   PubMed Web of Science ®Google Scholar
• Hammacher A, Hellman U, Johnsson A, Ostman A, Gunnarsson K, Westermark B, . A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J Biol Chem. 1988;263:16493–8.
   PubMed Web of Science ®Google Scholar
• Hart CE, Bailey M, Curtis DA, Osborn S, Raines E, Ross R, . Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry. 1990;29:166–72.
   PubMed Web of Science ®Google Scholar
• Sensebe L, Krampera M, Schrezenmeier H, Bourin P, Giordano R. Mesenchymal stem cells for clinical application. Vox Sang. 2010;98:93–107.
   PubMed Web of Science ®Google Scholar
• Bourin P, Gadelorge M, Peyrafitte JA, Fleury-Cappellesso S, Gomez M, Rage C, . Mesenchymal progenitor cells: tissue origin, isolation and culture. Transfus Med Hemother. 2008;35:160–7.
   PubMed Web of Science ®Google Scholar
• Klass BR, Grobbelaar AO, Rolfe KJ. Transforming growth factor beta1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad Med J. 2009;85:9–14.
   PubMed Web of Science ®Google Scholar
• Fonsatti E, Maio M. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med. 2004;2:18.
   PubMedGoogle Scholar
• Bundesärztekammer. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). 2010;Gesamtnovelle 2005, 2. Richtlinienanpassung 2010.
   Google Scholar
• EDQM. European Pharmacopoeia. 7th ed., Chapter 2.6.14. Stuttgart, Germany: Deutscher Apotheker Verlag; 2008.
   Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, . Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–41.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, . Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–86.
   PubMed Web of Science ®Google Scholar
• Sensebe L, Bourin P, Tarte K. Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther. 2011;22:19–26.
   PubMedGoogle Scholar
• Reinhardt J, Stühler A, Blümel J. Safety of bovine sera for production of mesenchymal stem cells for therapeutic use. Hum Gene Ther. 2011;22:776.
   Google Scholar
• Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ, . Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther. 2004;9:747–56.
   PubMed Web of Science ®Google Scholar
• Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le BK. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica. 2007;92:1208–15.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, . Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002;99:8932–7.
   PubMed Web of Science ®Google Scholar
• Martin MJ, Muotri A, Gage F, Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med. 2005;11:228–32.
   PubMed Web of Science ®Google Scholar
• Asher DM. Bovine sera used in the manufacture of biologicals: current concerns and policies of the US Food and Drug Administration regarding the transmissible spongiform encephalopathies. Dev Biol Stand. 1999;99:41–4.
   PubMedGoogle Scholar
• Brown P, Will RG, Bradley R, Asher DM, Detwiler L. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis. 2001;7:6–16.
   PubMed Web of Science ®Google Scholar
• Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC. A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther. 2010;1:8.
   PubMedGoogle Scholar
• Capelli C, Gotti E, Morigi M, Rota C, Weng L, Dazzi F, . Minimally manipulated whole human umbilical cord is a very rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy. 2011;13:786–801.
   PubMed Web of Science ®Google Scholar
• Ploederl K, Strasser C, Hennerbichler S, Peterbauer-Scherb A, Gabriel C. Development and validation of a production process of platelet lysate for autologous use. Platelets. 2010;22:204–9.
   PubMedGoogle Scholar
• Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D, . Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells. 2009;27:2331–41.
   PubMed Web of Science ®Google Scholar
• Chevallier N, Anagnostou F, Zilber S, Bodivit G, Maurin S, Barrault A, . Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials. 2010;31:270–8.
   PubMed Web of Science ®Google Scholar
• Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, . Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005;205:228–36.
   PubMed Web of Science ®Google Scholar
• Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, . Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 2007;47:1436–46.
   PubMed Web of Science ®Google Scholar
• Su CY, Kuo YP, Lin YC, Huang CT, Tseng YH, Burnouf T. A virally inactivated functional growth factor preparation from human platelet concentrates. Vox Sang. 2009;97:119–28.
   PubMedGoogle Scholar
• von Bonin M, Kiani A, Platzbecker U, Schetelig J, Holig K, Oelschlagel U, . Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation. Leuk Res. 2009;33:e215–17.
   PubMedGoogle Scholar
• Blande IS, Bassaneze V, Lavini-Ramos C, Fae KC, Kalil J, Miyakawa AA, . Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion. 2009;49: 2680–5.
   PubMed Web of Science ®Google Scholar
• Salvade A, Della MP, Gaddi D, Gatto F, Villa A, Bigoni M, . Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng Part C Methods. 2010;16:201–14.
   PubMed Web of Science ®Google Scholar
• Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, . Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion. 2008;48:1558–66.
   PubMed Web of Science ®Google Scholar
• Roth WK. Quarantine plasma: quo vadis? Transfus Med Hemother. 2010;37:118–22.
   PubMedGoogle Scholar
• Schrezenmeier H, Seifried E. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang. 2010; 99:1–15.
   PubMed Web of Science ®Google Scholar
• Rojewski MT, Weber BM, Schrezenmeier H. Phenotypic characterization of mesenchymal stem cells from various tissues. Transfus Med Hemother. 2008;35:168–84.
   PubMed Web of Science ®Google Scholar
• Fierro F, Illmer T, Jing D, Schleyer E, Ehninger G, Boxberger S, . Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif. 2007;40:355–66.
   PubMed Web of Science ®Google Scholar
• Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006;24:99–146.
   PubMed Web of Science ®Google Scholar
• Ding W, Knox TR, Tschumper RC, Wu W, Schwager SM, Boysen JC, . Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch. Blood. 2010;116:2984–93.
   PubMed Web of Science ®Google Scholar
• Jenhani F, Durand V, Ben AN, Thallet S, Ben OT, Bejaoui M, . Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells. Transplant Proc. 2011;43:639–43.
   Google Scholar
• Tokunaga A, Oya T, Ishii Y, Motomura H, Nakamura C, Ishizawa S, . PDGF receptor beta is a potent regulator of mesenchymal stromal cell function. J Bone Miner Res. 2008;23:1519–28.
   PubMed Web of Science ®Google Scholar
• Nedeau AE, Bauer RJ, Gallagher K, Chen H, Liu ZJ, Velazquez OC. A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells. Exp Cell Res. 2008;314:2176–86.
   PubMed Web of Science ®Google Scholar
• Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, . The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007;25: 1737–45.
   PubMed Web of Science ®Google Scholar
• Kroeze KL, Jurgens WJ, Doulabi BZ, van Milligen FJ, Scheper RJ, Gibbs S. Chemokine-mediated migration of skin-derived stem cells: predominant role for CCL5/RANTES. J Invest Dermatol. 2009;129:1569–81.
   Google Scholar
• Fu X, Han B, Cai S, Lei Y, Sun T, Sheng Z. Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing. Wound Repair Regen. 2009;17:185–91.
   PubMedGoogle Scholar
• Kim YS, Park HJ, Hong MH, Kang PM, Morgan JP, Jeong MH, . TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium. Front Biosci. 2009;14:2845–56.
   Web of Science ®Google Scholar
• Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep. 2009;61:22–32.
   PubMed Web of Science ®Google Scholar
• van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med (Berl). 1996;74:13–33.
   PubMed Web of Science ®Google Scholar
• Cheng P, Gao ZQ, Liu YH, Xue YX. Platelet-derived growth factor BB promotes the migration of bone marrow-derived mesenchymal stem cells towards C6 glioma and up-regulates the expression of intracellular adhesion molecule-1. Neurosci Lett. 2009;451:52–6.
   PubMedGoogle Scholar
• Ruster B, Gottig S, Ludwig RJ, Bistrian R, Muller S, Seifried E, . Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood. 2006; 108:3938–44.
   PubMed Web of Science ®Google Scholar
• Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4:206–16.
   PubMed Web of Science ®Google Scholar
• Ip JE, Wu Y, Huang J, Zhang L, Pratt RE, Dzau VJ. Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell. 2007;18:2873–82.
   PubMed Web of Science ®Google Scholar
• Goedecke A, Wobus M, Krech M, Munch N, Richter K, Holig K, . Differential effect of platelet-rich plasma and fetal calf serum on bone marrow-derived human mesenchymal stromal cells expanded in vitro. J Tissue Eng Regen Med. 2011;5:648–54.
   PubMedGoogle Scholar
• Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J, Zander AR. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol. 2007;213:18–26.
   PubMed Web of Science ®Google Scholar
• Kocaoemer A, Kern S, Kluter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells. 2007; 25:1270–8.
   PubMed Web of Science ®Google Scholar
• Flemming A, Schallmoser K, Strunk D, Stolk M, Volk HD, Seifert M. Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate. J Clin Immunol. 2011;31:1143–56.
   PubMed Web of Science ®Google Scholar
• Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noel D. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther. 2010;1:2.
   PubMed Web of Science ®Google Scholar
• Halfon S, Abramov N, Grinblat B, Ginis I. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 2011;20: 53–66.
   PubMed Web of Science ®Google Scholar
• Zhang A, Wang Y, Ye Z, Xie H, Zhou L, Zheng S. Mechanism of TNF-alpha-induced migration and hepatocyte growth factor production in human mesenchymal stem cells. J Cell Biochem. 2010;111:469–75.
   PubMedGoogle Scholar
• Egea V, von BL, Schichor C, Berninger B, Popp T, Neth P, . TNF-alpha respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma. Cell Death Differ. 2011;18:853–63.
   PubMed Web of Science ®Google Scholar
• Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, . A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res. 2008;18:846–57.
   PubMed Web of Science ®Google Scholar
• Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol. 2007;149:353–63.
   PubMed Web of Science ®Google Scholar
• Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol. 2011;6:457–78.
   PubMed Web of Science ®Google Scholar
• de Vasconcellos JF, Laranjeira ABA, Zanchin NIT, Otubo R, Vaz TH, Cardoso AA, . Increased CCL2 and IL-8 in the bone marrow microenvironment in acute lymphoblastic leukemia. Ped Blood Cancer. 2011;56:568–77.
   PubMedGoogle Scholar